Lyell Immunopharma, Inc. (NASDAQ:LYEL) has caught the attention of institutional...

Published on 3 Feb 2025 on Simply Wall St. · via Yahoo Finance

Key Insights Given the large stake in the stock by institutions, Lyell Immunopharma's stock price...

Read the rest of the article

Start tracking your investments with Statfolio

Key Insights Given the large stake in the stock by institutions, Lyell Immunopharma's stock price...

Simply Wall St. · via Yahoo Finance 3 Feb 2025

Lyell Immunopharma Shares Plunge On One Patient Death In CAR-T Cell Therapy Cancer Trial Lyell Im...

Benzinga · via Yahoo Finance 20 Jun 2024

Key Insights Institutions' substantial holdings in Lyell Immunopharma implies that they have sign...

Simply Wall St. via Yahoo Finance 17 Mar 2024

Net Loss: Reported a net loss of $52.9 million for Q4 and $234.6 million for the full year 2023.R...

GuruFocus.com via Yahoo Finance 28 Feb 2024

Key Insights Institutions' substantial holdings in Lyell Immunopharma implies that they have sign...

Simply Wall St. via Yahoo Finance 9 Oct 2023

Shareholders in Lyell Immunopharma, Inc. (NASDAQ:LYEL) may be thrilled to learn that the analysts...

Simply Wall St. via Yahoo Finance 29 Aug 2023

Over the last month the Lyell Immunopharma, Inc. (NASDAQ:LYEL) has been much stronger than before...

Simply Wall St. via Yahoo Finance 1 Jun 2023

Lyell Immunopharma, Inc.'s (NASDAQ:LYEL) price-to-sales (or "P/S") ratio of 7x might make it look...

Simply Wall St. via Yahoo Finance 17 Apr 2023

Key Insights Given the large stake in the stock by institutions, Lyell Immunopharma's stock price...

Simply Wall St. via Yahoo Finance 26 Mar 2023

Lyell Immunopharma (LYEL) came out with a quarterly loss of $0.03 per share versus the Zacks Cons...

Zacks via Yahoo Finance 28 Feb 2023